Uldum S A, Søndergård-Andersen J, Skov Jensen J, Lind K
Nesseria Department, Statens Seruministitut, Copenhagen, Denmark.
Eur J Clin Microbiol Infect Dis. 1990 Mar;9(3):221-3. doi: 10.1007/BF01963843.
A commercial enzyme immunoassay (Platelia Mycoplasma, Diagnostics Pasteur) for the diagnosis of Mycoplasma pneumoniae [corrected] infections was evaluated and found not to be suitable for the purpose. More than 80% of healthy persons and patients with non-Mycoplasma pneumoniae respiratory infection, all with a negative Mycoplasma pneumoniae complement fixation test, had a positive EIA. Paired sera did not show the positive correlation between a rise in complement fixation titre and the EIA ratio reported by the manufacturer.
对一种用于诊断肺炎支原体感染的商业酶免疫测定法(百得利亚肺炎支原体检测试剂盒,巴斯德诊断公司)进行了评估,发现其不适用于此目的。超过80%的健康人和非肺炎支原体呼吸道感染患者,所有这些人的肺炎支原体补体结合试验均为阴性,但酶免疫测定结果却呈阳性。配对血清并未显示出补体结合滴度升高与制造商报告的酶免疫测定比值之间存在正相关关系。